AP NEWS
This content is a press release from our partner Business Wire. The AP newsroom and editorial departments were not involved in its creation.
PRESS RELEASE from provider: Business Wire
This content is a press release from our partner Business Wire. The AP newsroom and editorial departments were not involved in its creation.

Axonics® to Participate in Upcoming Investor Events

March 7, 2019

IRVINE, Calif.--(BUSINESS WIRE)--Mar 7, 2019--Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company focused on the development and commercialization of novel implantable Sacral Neuromodulation (“SNM”) devices for the treatment of  urinary and bowel dysfunction, today announced that members of the management team will participate in the following upcoming investor events:

  • Management is scheduled to present at the Barclays Global Healthcare Conference, Thursday, March 14, at 9:30 am ET in Miami Beach, FL, and will be available for one-on-one meetings.
  • Management will also be available for one-on-one meetings at the Morgan Stanley Healthcare Corporate Access Day, Tuesday, March 19, in Boston.

To access the live webcast of the presentation at the Barclays Global Healthcare Conference, please visit the Events & Presentations page of the Investors section of the Company’s website at ir.axonicsmodulation.com. A replay of the webcast will be available shortly after the conclusion of the presentation and will be archived on the Company’s website for 90 days.

About Axonics Modulation Technologies, Inc.

Axonics, based in Irvine, CA, is focused on the development and commercialization of a novel implantable SNM system for patients with urinary and bowel dysfunction. The Axonics r-SNM® System is the first rechargeable Sacral Neuromodulation system approved for sale in Europe, Canada and Australia, and the first SNM system to gain CE mark for full-body MRI conditional labeling. Premarket Approval (PMA) for the r-SNM System is currently pending with the U.S. FDA. For more information, visit the Company’s website at www.axonicsmodulation.com.

View source version on businesswire.com:https://www.businesswire.com/news/home/20190307005162/en/

CONTACT: Axonics’ Contact

Axonics Modulation Technologies, Inc.

Dan Dearen, +1-949-396-6320

President & Chief Financial Officer

ir@axonics.comInvestor & Media Contact

W2Opure

Matt Clawson, +1-949-370-8500

mclawson@w2ogroup.com

KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA

INDUSTRY KEYWORD: TECHNOLOGY ELECTRONIC DESIGN AUTOMATION HARDWARE OTHER TECHNOLOGY HEALTH BIOTECHNOLOGY OTHER HEALTH RESEARCH OTHER SCIENCE SCIENCE

SOURCE: Axonics Modulation Technologies, Inc.

Copyright Business Wire 2019.

PUB: 03/07/2019 06:00 AM/DISC: 03/07/2019 06:01 AM

http://www.businesswire.com/news/home/20190307005162/en